| Q44205214 | Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma |
| Q37083901 | Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer |
| Q80044594 | Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer |
| Q35335157 | Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma? |
| Q36121595 | Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder. |
| Q35167655 | Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma |
| Q35188024 | GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis |
| Q38602274 | GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. |
| Q26766098 | Glucose metabolism in gastric cancer: The cutting-edge |
| Q37725533 | Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis |
| Q50127858 | Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis |
| Q37579133 | HIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies - after photodynamic diagnosis (PDD). |
| Q42488078 | Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy |
| Q92618871 | Immunhistochemical expression of GLUT1 is associated with low grade and low stage of urinary bladder cancer |
| Q40182987 | Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma |
| Q33714473 | Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis? |
| Q36001482 | Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma. |
| Q36683880 | Nuclear receptors and the Warburg effect in cancer |
| Q34332053 | Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells |
| Q28076454 | Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects |
| Q33732986 | Revisiting the hallmarks of cancer |
| Q64080005 | Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer |
| Q34204238 | Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters |
| Q35670459 | ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma |